(Q51678183)

9 April 2018

title

DOPA and amino acid levels in plasma and cerebrospinal fluid of patients with parkinson's disease before and during treatment with L-dOPA (English)

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

22 February 2023

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

22 February 2023

author name string

T. A. Hare

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4708057

22 February 2023

B. L. Beasley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4708057

22 February 2023

R. A. Chambers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4708057

22 February 2023

D. H. Boehme

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4708057

22 February 2023

W. H. Vogel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4708057

22 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4708057

22 February 2023

publication date

1 May 1973

1 reference

9 April 2018

18 May 1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4708057

full work available at URL

22 February 2023

https://api.elsevier.com/content/article/PII:0009898173904385?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

https://api.elsevier.com/content/article/PII:0009898173904385?httpAccept=text/plain

22 February 2023

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

22 February 2023

1 reference

9 April 2018

volume

45

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

page(s)

273-280

1 reference

9 April 2018

Aromatic Amino Acids and Modification of Parkinsonism

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Absorption and Metabolism of Levodopa

22 February 2023

2

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

22 February 2023

Pharmacological Reviews

3

18

925

Hornykiewicz

1966

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Hypoprolinemia in parkinsonism; a case report

22 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Rapid estimation of DOPA in physiological fluids using the amino acid analyzer

22 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Automatic analysis of amino acids. Effect of resin cross-linking and operational variables on resolution

22 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The free amino acids in human cerebrospinal fluid

22 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Plasma-aminoacid levels in Huntington's chorea

22 February 2023

12

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Clinical and cerebrospinal fluid changes in parkinsonian patients treated with L‐3, 4‐dihydroxyphenylalanine (L‐dopa)

22 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

On the presence of 3-hydroxytyramine in brain.

22 February 2023

17

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The action of antidecarboxylases on the conversion of 3,4-dihydroxyphenylalanine to dopamine in vivo

22 February 2023

18

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

22 February 2023

19

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.

22 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Decrease in Adrenal Tyrosine Hydroxylase and Increase in Norepinephrine Synthesis in Rats Given L-Dopa

22 February 2023

21

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brain

22 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

L-Dihydroxyphenylalanine: Effect on S -Adenosylmethionine in Brain

22 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

L-Dopa: Disaggregation of Brain Polysomes and Elevation of Brain Tryptophan

22 February 2023

25

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The effect of L-Dopa on monoamine metabolites in Parkinson's disease

22 February 2023

28

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

Analysis in human plasma of 3-methoxytyrosine: a metabolite of Dopa

22 February 2023

29

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The metabolism of orally administered l-DOPA in Parkinsonism

22 February 2023

30

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

The metabolism of L-3,4-dihydroxyphenylalanine in man

22 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/0009-8981(73)90438-5

22 February 2023

Identifiers

1 reference

9 April 2018

1 reference

9 April 2018